Job offer

Product Manager – Portfolio Optimization

Main Responsibilities:

Lead the process of launching new products in a commercial perspective.
Translate the launch strategy into action plans to achieve successful and sustainable product launches
Leads cross functional initiatives or projects related to the optimization of the product portfolio in various stages of the lifecycle.
Support the 5Y Strategic Plan to deliver expected growth
Monitor market in order to identify new opportunities for business growth

Ideal Candidate:

Strategic thinking: Strong analytical skills for product and market analysis
Process-Oriented: Business driven and with problem Solver mindset.
Strong Communicator and Highly Collaborative: Effective collaboration and strong networking skills within cross-functional teams
High learning agility and open mindset for change
Mission-Aligned with company’s vision and fit for growth plan

Apply

© 2022, Farmaprojects. All Rights Reserved.

For more information and updates regarding available dossiers and dossiers under development please contact Sales Department.
DISCLAIMER: Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s). Based on exemption under art. 5(2) of the Regulation (EC) No 469/2009 concerning the supplementary protection certificate for medicinal products Apixaban, Rivaroxaban and Ticagrelor, which are protected by SPCs in Poland, can be manufactured and offered only for the purpose of export to non-EU countries, provided all requirements of the Regulation are met.

© 2022, Farmaprojects. All Rights Reserved.

For more information and updates regarding available dossiers and dossiers under development please contact Sales Department.
DISCLAIMER: Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s). Based on exemption under art. 5(2) of the Regulation (EC) No 469/2009 concerning the supplementary protection certificate for medicinal products Apixaban, Rivaroxaban and Ticagrelor, which are protected by SPCs in Poland, can be manufactured and offered only for the purpose of export to non-EU countries, provided all requirements of the Regulation are met.